Clopidogrel monotherapy after one year of dual antiplatelet therapy shows superior outcomes compared to aspirin for secondary chronic maintenance in heart patients.
← News
Tech for Good Tech for Good Frontiers
Clopidogrel seems to outperform aspirin for secondary chronic maintenance therapy
One Year years Treatment duration before switch
High-Risk Bleeding Patients And Complex PCI Cases Patient population benefit